TITLE:
Non-Small Cell Lung Cancer: Therapeutic and Evolutionary Aspects in Cote d’Ivoire
AUTHORS:
Touré Moctar, Kouassi Kouamé Konan Yvon, Séka Evrard Narcisse, Traoré Kadjatou, Traoré Asmaho Danielle, Odo Bitti Addé, Oumou Kimso, Kagambega Arsène Gaëtan, Adoubi Innocent
KEYWORDS:
Non-Small Cell Lung Cancer, Treatment, Evolution
JOURNAL NAME:
Advances in Lung Cancer,
Vol.7 No.1,
March
30,
2018
ABSTRACT: Non-small cell lung cancer (NSCLC) is a heterogeneous group of malignancies
including squamous cell carcinoma, adenocarcinoma, bronchioloalveolar carcinoma
and large cell carcinoma. They are known to be of poor prognosis, despite a
better understanding of bronchial oncogenesis. This descriptive retrospective
study carried out over three years (January 2013 to December 31st,
2016) at the Oncology Department of the Treichville University Hospital in
Abidjan was aimed to assess the efficacy of new treatments for NSCLC in Cote d’Ivoire
and to specify their benefit in terms of quality of life, comfort and overall
survival. This 77 patients study, found that NSCLC, the most frequent of which
is squamous cell carcinoma, occurs in relatively young subjects, smokers (91%)
diagnosed at a locally advanced or metastatic stage (89%). Cisplatin base multi-drug
chemotherapy was mostly used (71%). Combined all treatments, there was a significant
clinical gain. However, no complete response was observed. Hematological and
digestive toxicities were seen in more than 30% of cases. Overall survival was
of 9 months on average. This study is an advocate to optimize primary
prevention policies for a cancer with poor prognosis despite the development of
new treatments such as target therapies.